Clinical Trial Update: Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating Ivonescimab and Cadonilimab in combination with chemotherapy for extensive-stage small cell lung cancer; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Cadonilimab
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Sichuan University | Conditions: Small Cell Lung Cancer | Phase 2 | Status: RECRUITING